• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us

Pfizer

Pfizer announces promising results for RSV vaccine

November 10, 2022 By Lalita Panicker Leave a Comment

Barney Graham, a former scientist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), was thrilled when Pfizer announced encouraging results from an experimental vaccine that could protect against a major childhood killer. In a press release, the company said immunizing pregnant women with its vaccine against respiratory syncytial virus (RSV) protected their babies from severe […]

Filed Under: Featured, Infectious diseases, International, Medicine and Research, News, Newsletter Tagged With: Pfizer, RSV

Pfizer set to test new COVID-19 pill on long-covid patients

November 9, 2022 By Lalita Panicker Leave a Comment

Plans for the first test of whether Pfizer’s COVID-19 pill known as Paxlovid can alleviate Long Covid were unveiled last week, as organizers said they expect to begin recruiting 1700 volunteers in January 2023. Patient groups and researchers have long sought such a trial to study whether suppressing the SARS-CoV-2 coronavirus can reduce Long COVID’s debilitating […]

Filed Under: Featured, Infectious diseases, Medicine and Research, News, Newsletter Tagged With: COVID-19, Long COVID, Pfizer

Pfizer quadruples price of COVID-19 vaccines

October 26, 2022 By Lalita Panicker Leave a Comment

Pfizer’s plan to quadruple US prices for its COVID-19 vaccine next year is beyond Wall Street’s expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said. www.reuters.com/business/healthcare-pharmaceuticals/pfizer-covid-vaccine-price-hike-seen-giving-revenue-boost-years-2022-10-21/? The drugmaker, which developed and sells the vaccine with Germany’s BioNTech (22UAy.DE), said on Thursday evening […]

Filed Under: Featured, Infectious diseases, International, News, Newsletter Tagged With: COVID-19, Pfizer

Moderna sues rival Pfizer/BioNTech over patent violation of mRNA Covid vaccine

September 2, 2022 By Lalita Panicker Leave a Comment

Moderna and Pfizer BioNTech

The vaccine manufacturer Moderna has sued pharma major Pfizer and BioNTech, claiming that its rivals’ Covid-19 shot violates its patents protecting its ground-breaking technology www.nytimes.com/2022/08/26/business/moderna-covid-vaccine-lawsuit.html Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology. Moderna, which is based in Cambridge, Mass., sued […]

Filed Under: Featured, International, Medicine and Research Tagged With: BioNTech, Moderna, mRNA vaccines, Pfizer

Paxlovid appears to reduce the risk of dying from COVID-19 by 79% in those over 65

September 2, 2022 By Lalita Panicker Leave a Comment

Pfizer - Paxlovid

The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients aged 65 and older, according to a new study published in The New England Journal of Medicine. The pill, which is a combination of the drugs nirmatrelvir and ritonavir, received FDA emergency use authorization in […]

Filed Under: Featured Stories, International, Medicine and Research Tagged With: antiviral, COVID, Paxlovid, Pfizer

Global heating will make you ill — just not how you think it will

September 23, 2021 By Lalita Panicker Leave a Comment

Coming as it does at a time when COVID-19 resolutely refuses to pack up and go away, the 2021 United Nations Climate Change Conference (COP26) in Glasgow this November will likely discuss not only international climate action but the impact of climate on health issues as well.  As the Lancet Countdown 2020 Report explained, no continent, country, or community is immune from […]

Filed Under: Featured, Featured Story, Infectious diseases, News, Opinion Tagged With: COP26, Kerala, Nipah, Nipah virus, Pfizer

Pfizer vaccine talks ongoing with expert group

July 23, 2021 By Kerean Watts Leave a Comment

The alleged involvement of Pfizer in the patent battle has led to scrutiny. Image credit: Roman Tiraspolsky / 123rf. Pfizer vaccine concept.

An expert government panel is in talks regarding the BioNTech / Pfizer vaccine, Union Health Minister Mankush Mandaviya told the Lok Sabha on Friday. The Minister said “an expert group of the Indian government is still in talks with Pfizer over COVID vaccine supply.” United States State Department spokesperson Ned Price has announced that the […]

Filed Under: Infectious diseases, Medicine and Research, National, News, Science and Technology Tagged With: coronavirus, COVID-19, Moderna, Pfizer, vaccine, vaccines

Pfizer/BioNTech vaccine: Less effective against Delta variant?

July 7, 2021 By Kerean Watts Leave a Comment

The alleged involvement of Pfizer in the patent battle has led to scrutiny. Image credit: Roman Tiraspolsky / 123rf. Pfizer vaccine concept.

The Pfizer/BioNTech vaccine against COVID-19 has registered a lower level of efficacy in preventing the Delta variant first identified in India, according to new data from Israel.  Effectiveness of the vaccine has dropped to 64 percent in preventing infection as the Delta variant spreads in Israel, now accounting for ninety percent of the country’s cases. […]

Filed Under: Infectious diseases, International, Medicine and Research, News, Science and Technology, Social issues Tagged With: BioNTech, coronavirus, COVID-19, Pfizer, vaccine, vaccines

Pfizer vaccine on the cusp of securing Indian approval, CEO says

June 24, 2021 By Kerean Watts Leave a Comment

The alleged involvement of Pfizer in the patent battle has led to scrutiny. Image credit: Roman Tiraspolsky / 123rf. Pfizer vaccine concept.

The Pfizer vaccine against COVID-19 is on the verge of securing approval for use in India. This is according to the drugmaker’s chief executive officer Albert Bourla who, speaking at a virtual event, said they were in the “final stages” of receiving the nod and said “I hope very soon we will finalise an agreement […]

Filed Under: Infectious diseases, Medicine and Research, National, News, Science and Technology Tagged With: coronavirus, COVID-19, industry, Pfizer, pharma, regulation, vaccination, vaccines

Pfizer withdraws approval application in India

February 5, 2021 By Kerean Watts Leave a Comment

Pfizer world headquarters in New York City, USA. Pfizer is one of two COVID vaccine candidate manufacturers to request emergency use authorisation in India. Image credit: Jim.henderson, Public domain, via Wikimedia Commons.

Drugmaker Pfizer has rescinded its emergency use authorisation application for its vaccine candidate against COVID-19. However, it intends to resubmit.  The pharmaceutical giant sought emergency use authorisation for its vaccine in India last year but “has decided to withdraw its application at this time” according to a company spokesperson. Pfizer’s vaccine showed promising results in […]

Filed Under: Medicine and Research, National, News Tagged With: coronavirus, COVID-19, Pfizer, vaccines

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

Articles

  • Renewed fears of a bird flu pandemic; The latest health stories from around the world
  • More oversight needed for “gain of function” research says expert panel; The latest health stories from around the world
  • Marion Biotech to be investigated by Indian drug regulator
  • Sesame to be added to list of major food allergens
  • Approval of Alzheimer’s drug “rife with irregularities”

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2023 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.